Skip to main content

Table 2 Plaque characteristics

From: Association between daily glucose fluctuation and coronary plaque properties in patients receiving adequate lipid-lowering therapy assessed by continuous glucose monitoring and optical coherence tomography

  Overall (n =166) Tertile 1 (MAGE <49.1) (n =55) Tertile 2 (49.1 ≤ MAGE <85.3) (n = 50) Tertile 3 (85.3 ≤ MAGE) (n =61) P value
Culprit lesion 64 (38.6) 20 (36.4) 21 (42.0) 23 (37.7) 0.83
Lipid-rich plaque 91 (54.8) 22 (40.0) 31 (62.0) 38 (62.3) 0.026
Lipid length (mm) 16.1 ± 6.7 13.2 ± 5.0 15.0 ± 6.2 19.5 ± 7.1 <0.001
Mean lipid arc 183.1 ± 51.9 147.1 ± 37.2 173.5 ± 43.7 223.4 ± 41.0 <0.001
Calcification 84 (50.6) 25 (45.4) 29 (58.0) 30 (49.2) 0.42
Calcification length (mm) 5.3 ± 3.8 5.6 ± 3.7 4.3 ± 2.7 6.1 ± 4.6 0.21
Mean calcification arc 119.6 ± 71.3 125.8 ± 73.0 90.5 ± 42.6 141.7 ± 83.2 0.019
TCFA 37 (22.3) 4 (7.3) 9 (18.0) 24 (39.3) <0.001
Microchannel 99 (59.6) 23 (41.8) 29 (58.0) 47 (77.0) 0.001
Thrombus 13 (7.8) 1 (1.8) 5 (10.0) 7 (11.5) 0.12
Plaque location      0.79
RCA
 Proximal 28 (16.9) 8 (14.5) 9 (18.0) 11 (18.0)  
 Mid 12 (7.2) 5 (9.1) 3 (6.0) 4 (6.6)  
 Distal 8 (4.8) 1 (1.8) 5 (10.0) 2 (3.3)  
LAD
 Proximal 34 (20.5) 11 (20.0) 9 (18.0) 14 (22.9)  
 Mid 27 (16.2) 8 (14.5) 10 (20.0) 9 (14.7)  
 Distal 10 (6.0) 4 (7.3) 4 (8.0) 2 (3.3)  
LCx
 Proximal 13 (7.8) 7 (12.7) 1 (2.0) 5 (8.2)  
 Mid 26 (15.7) 8 (14.5) 7 (14.0) 11 (18.0)  
 Distal 8 (4.8) 3 (5.5) 2 (4.0) 3 (4.9)  
  1. Values are mean ± SD or no. (%) LAD: left anterior descending artery; LCx: left circumflex artery; RCA: right coronary artery; TCFA: thin-cap fibroatheroma